High serum parathyroid hormone and calcium are risk factors for hypertension in Japanese patients

DOI Web Site PubMed 参考文献20件 オープンアクセス
  • Yagi Shusuke
    Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Aihara Ken-ichi
    Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Kondo Takeshi
    Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Endo Itsuro
    Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Hotchi Junko
    Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Ise Takayuki
    Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Iwase Takashi
    Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Akaike Masashi
    Department of Medical Education, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Matsumoto Toshio
    Department of Medicine and Bioregulatory Sciences, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan
  • Sata Masataka
    Department of Cardiovascular Medicine, The University of Tokushima Graduate School of Health Biosciences, Tokushima 770-8503, Japan

この論文をさがす

説明

Excess parathyroid hormone (PTH), known as primary hyperparathyroidism (pHPT), results in hypercalcemia and bone loss. Recent studies have shown that PTH is associated with the occurrence of hypertension in Western countries; however, controversy remains regarding high serum levels of PTH and calcium as risk factors for hypertension in Japanese patients. We retrospectively enrolled 114 consecutive Japanese patients who visited our hospital for examination and treatment of hypercalcemia and/or hypertension with serum calcium levels ≥9.8 mg/dL. To estimate the prevalence of hypertension, the patients were categorized according to calcium levels into hypercalcemic (10.2-13.4 mg/dL) and normocalcemic (9.8-10.1 mg/dL) groups, which were further categorized into high PTH (50-440 pg/mL) and low PTH (8-49 pg/mL) groups. The prevalence of hypertension was higher in patients with hypercalcemia than in patients with normocalcemia in both the high and low PTH groups. The prevalence of hypertension was higher in patients with high serum PTH levels than in patients with low serum PTH levels in both the hypercalcemic and normocalcemic groups. Logistic multiple regression analysis determined that serum calcium (P < 0.05) and PTH (P < 0.01) levels were positive contributors to hypertension. In conclusion, high serum levels of PTH and calcium are risk factors for hypertension in Japanese patients.

収録刊行物

  • Endocrine Journal

    Endocrine Journal 61 (7), 727-733, 2014

    一般社団法人 日本内分泌学会

参考文献 (20)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ